Abstract Details

Title SEP-228791, a Novel Dopamine and Norepinephrine Re-Uptake Inhibitor, Has Anti-Parkinsonian Actions, without Eliciting Dyskinesia, in the MPTP-Lesioned Primate Model of Parkinson's Disease

Topic Movement Disorders

Presentation(s) (-)

Poster/Presentation
Number 171

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Tom H. Johnston, PhD (Toronto Western Research Institute)	No disclosure on file
Susan Fox, MD, FAAN (Toronto Western Hospital)	The institution of Dr. Fox has received research support from MJFF/Safra. The institution of Dr. Fox has received research support from Parkinson Canada. The institution of Dr. Fox has received research support from NIH. Dr. Fox has received publishing royalties from a publication relating to health care.
	No disclosure on file
	No disclosure on file
	No disclosure on file
Mena Samaan, MD	No disclosure on file
Jonathan M. Brotchie, PhD (Clinical Studies Research Cen/ TWH)	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��